THESEUS PHARMACEUTICALS INC (THRX)
US88369M1018 - Common Stock
Theseus Pharmaceuticals Announces Closing of Tender Offer
/PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus" or the "Company"), a clinical-stage biopharmaceutical company focused on improving the...
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates PGTI, X, THRX, AYX
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates DSKE, THRX, CONN
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX, CONN
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Shareholder Alert: Ademi LLP investigates whether Theseus Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Concentra
/PRNewswire/ -- Ademi LLP is investigating Theseus (NASDAQ: THRX) for possible breaches of fiduciary duty and other violations of law in its transaction with...
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right
/PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus" or the "Company"), a clinical-stage biopharmaceutical company focused on improving the...
Theseus Pharma fires CEO and medical chief (NASDAQ:THRX)
Theseus Pharmaceuticals (THRX) terminates CEO and medical chief as part of layoffs. CFO Bradford Dahms appointed as President and board member. Read more here.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the week with a breakdown of the biggest pre-market stock movers that are worth watching on Monday morning!
Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC
/PRNewswire/ -- On November 22, 2023, the board of directors (the Board) of Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company) received an...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a breakdown of all the biggest pre-market stock movers traders need to know about this morning!
Theseus Pharmaceuticals explores strategic options; cuts workforce by 72% (NASDAQ:THRX)
Theseus Pharmaceuticals implements significant workforce reduction and explores strategic alternatives to enhance shareholder value, including asset sale or...
Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
/PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the...
Theseus Pharmaceuticals Announces Business Highlights and Reports Second Quarter 2023 Financial Results
IND submission for THE-349 in EGFR-mutant NSCLC expected in Q4 2023 Development candidate nomination for BCR-ABL program in CML and Ph+ ALL expected in H1 2024...
PLUG Stock Alert: Plug Power Pops on Analyst Upgrade
Plug Power (PLUG) stock is getting a boost on Friday after Northland Securities analysts upgraded the hydrogen fuel cell company's shares.
Why Is Leslies (LESL) Stock Down 36% Today?
Leslies (LESL) stock is falling on Friday after the company released its preliminary earnings report for the third quarter of 2023.